Screener
Medtronic MDT Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Medtronic’s reported figures.
Based on trailing twelve months.
The source filing: Medtronic’s 10-K, filed June 18, 2026. Open the filing →
- Filed
- Jun 18, 2026, 4:27 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-044354
FAQ
- What is Medtronic's return on equity?
- Medtronic (MDT) reported return on equity of 9.8% in Q1 2026.
- How has Medtronic's return on equity changed year-over-year?
- Medtronic's return on equity increased by 3.8% year-over-year, from 9.5% to 9.8%.
- What is the long-term trend for Medtronic's return on equity?
- Over 5 years (2021 to 2026), Medtronic's return on equity has grown at a 6.9% compound annual growth rate (CAGR), from 7.1% to 9.8%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Medtronic's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude